Medical Negligence
Kingsley Napley LLP
Full Credential Description
We - Prostate Cancer & NHS Trust Negligence | Home | Services | Medical Negligence | Cancer Claims | Prostate Cancer | NHS Trust Claims | Contact Failures of a London Trust Which Led to 4-Year Delay in Diagnosing Prostate Cancer: Settlement Reached for £325,000 - Case Study Navigation: Medical Negligence > Cancer Claims > NHS Trust Claims > Case Studies Publication Date: 2024 Practice Area: Medical Negligence & Personal Injury NHS Trust Failures: We secured £325,000 for a patient whose prostate cancer diagnosis was delayed by four years due to systemic failures at a London NHS Trust, resulting in more advanced cancer and significantly compromised treatment options. Four-Year Diagnostic Delay: The case involved an unprecedented four-year delay in diagnosing prostate cancer, during which the patient presented multiple times with symptoms that should have prompted immediate investigation and specialist referral. NHS Trust System Failures: Our investigation revealed multiple systemic failures within the NHS Trust including inadequate follow-up procedures, poor communication between departments, failure to act on abnormal test results, and lack of appropriate specialist referral pathways. Cancer Progression: The four-year delay allowed the prostate cancer to progress from an early, highly treatable stage to a more advanced stage requiring more aggressive treatment with significantly reduced prospects for cure and long-term survival. Missed Opportunities: During the four-year period, there were numerous missed opportunities for diagnosis, including routine tests that were not properly followed up and symptoms that were not adequately investigated. Treatment Implications: The delayed diagnosis meant our client required more extensive surgery, additional radiation therapy, and hormone treatment that would not have been necessary with earlier detection and treatment.
Measurable Results
Failures of London trust led to 4-year delay in diagnosing prostate cancer with settlement reached for £325,000. Substantial compensation achieved for significant diagnostic delay that allowed cancer progression and required more aggressive treatment with reduced survival prospects.